Anastrozole vs Exemestane
Last updated
The key difference
Both are aromatase inhibitors approved for breast cancer. Anastrozole is non-steroidal and binds the enzyme reversibly. Exemestane is steroidal and binds it irreversibly, permanently disabling each enzyme molecule it hits.
Side by side
- Lowers elevated estradiol on testosterone therapy
- Can reduce estrogenic water retention and gynecomastia risk
- Lowers elevated estradiol on testosterone therapy
- Irreversible action avoids the estrogen rebound of reversible AIs
- Generally neutral effect on lipids at low doses
- Over-suppression of estradiol (joint pain, low libido, mood changes)
- Reduced bone mineral density with excessive use
- Adverse lipid changes
- Over-suppression of estradiol (joint pain, low libido, mood changes)
- Reduced bone mineral density with excessive use
- Fatigue
How Anastrozole works
Anastrozole reversibly inhibits the aromatase enzyme, which converts testosterone to estradiol. On TRT this lowers estradiol when it rises above the desired range. Because some estradiol is essential for male bone, lipid, libido, and mood health, over-suppression is harmful — dosing is conservative and lab-guided.
Full Anastrozole profile →How Exemestane works
Exemestane is a steroidal 'suicide' aromatase inhibitor: it binds aromatase irreversibly and permanently inactivates the enzyme, lowering the conversion of testosterone to estradiol. Because the enzyme must be regenerated, it avoids some of the rebound seen with reversible inhibitors. As with any aromatase inhibitor, some estradiol is essential for male health, so over-suppression is harmful and dosing is conservative and lab-guided.
Full Exemestane profile →Dosing shown is what research and community sources report, not a recommendation. For educational and research purposes only; not medical advice. How we source this